U.S. perfume sold as a cosmetic generally falls under MoCRA: the responsible person registers facilities, lists products with FDA, reports serious adverse events, maintains safety substantiation, and keeps accurate labels — even when an overseas partner fills the bottle.
MoCRA (Modernization of Cosmetics Regulation Act) applies to cosmetic products sold in the United States — including most body perfumes. The brand or designated responsible person typically must register manufacturing facilities, list each product with FDA, report serious adverse events within 15 business days, maintain safety substantiation records, and keep U.S.-compliant labeling with a responsible party name and address.
MoCRA does not mean FDA approves individual perfumes before sale. It sets registration, listing, record-keeping, and reporting duties for cosmetic responsible persons. IFRA conformity and batch documentation from your manufacturer support safety substantiation but do not replace these obligations — confirm your role with a qualified U.S. compliance advisor.
The Modernization of Cosmetics Regulation Act (MoCRA), enacted in late 2022, expanded FDA authority over cosmetics—including perfume sold as cosmetic products. MoCRA is not a fragrance-specific law, but perfume brands are subject to its facility, listing, safety, and adverse event rules.
MoCRA does not replace IFRA industry standards or EU cosmetic rules if you export. Think of it as the U.S. baseline for responsible persons marketing cosmetic products domestically.
Responsible persons must register facilities that manufacture or process cosmetic products for U.S. distribution and list products with FDA. Many private label brands are the responsible person even when an overseas partner fills the product.
Confirm whether your manufacturer’s U.S. entity handles any registration on your behalf—most brands still need clarity on who lists the product under their brand name.
MoCRA requires serious adverse event reports to FDA within 15 business days, with follow-up records. Train customer service to escalate rash, hospitalization, or similar reports—not only “smells weak” complaints.
Maintain complaint logs tied to batch or lot codes printed on packaging.
Brands must maintain evidence that products are safe under labeled conditions of use. For fragrance, that typically includes IFRA conformity, supplier safety assessments, stability data, and batch COAs archived by lot.
MoCRA grants FDA access to safety and manufacturing records during inspections—disorganized files become compliance risk.
U.S. cosmetic labeling still requires product identity, net quantity, ingredient declaration, and responsible person name and address. MoCRA reinforced record-keeping around labeling accuracy.
Fragrance allergens are not labeled in the EU Annex III style in the U.S. at the time of writing, but ingredient transparency rules differ by market—do not assume one label works globally without review.
Before scaling U.S. sales: confirm responsible person role, register and list products per current FDA timelines, collect batch documentation from your manufacturer, and document safety rationale for your formula and format.
Work with a U.S. regulatory advisor for your specific entity structure—especially if you import finished goods or sell through large retailers with vendor compliance portals.
MoCRA registration and listing apply once you have a defined product identity — formula, concentration, packaging, and U.S. label artwork. Before you commit to bulk MOQ, validate how shortlisted scents perform on skin and in your bottle format.
Brandsamor curates five fragrances from a short brand brief so you can compare wear and positioning before production decisions — the same starting point whether you sell domestically or plan a U.S. import-ready launch. Typical batch documentation such as IFRA conformity and COA supports your safety files; your manufacturer can discuss what they provide for each project.
Perfume sold for scent on the body is generally regulated as a cosmetic in the U.S., not pre-approved like a drug. MoCRA requires registration, listing, safety substantiation, and adverse event reporting — not a pre-market approval certificate for each scent. Product classification depends on intended use and claims.
Core duties for many cosmetic responsible persons include facility registration, product listing, serious adverse event reporting, safety substantiation records, accurate labeling, and access to records during FDA inspections. Specific timelines and exemptions depend on business size and role — confirm with a qualified advisor.
Generally yes when sold for scent on the body. Different rules may apply to air care or non-cosmetic claims—product classification depends on intended use and claims.
IFRA supports safety substantiation but does not replace MoCRA registration, listing, labeling, or adverse event obligations.
MoCRA includes limited small-business exemptions for certain requirements, but adverse event reporting and safety substantiation still apply broadly. Confirm eligibility with a qualified advisor.
Quality and Compliance · FDA MoCRA requirements perfume brands
U.S. perfume sold as a cosmetic generally falls under MoCRA: the responsible person registers facilities, lists products with FDA, reports serious adverse events, maintains safety substantiation, and keeps accurate labels — even when an overseas partner fills the bottle.
11 min read · By Brandsamor Editorial Team, Private label fragrance specialists
Published 2026-01-15 · Updated 2026-07-06
Reviewed by Brandsamor team
Sources: www.fda.gov
MoCRA (Modernization of Cosmetics Regulation Act) applies to cosmetic products sold in the United States — including most body perfumes. The brand or designated responsible person typically must register manufacturing facilities, list each product with FDA, report serious adverse events within 15 business days, maintain safety substantiation records, and keep U.S.-compliant labeling with a responsible party name and address.
MoCRA does not mean FDA approves individual perfumes before sale. It sets registration, listing, record-keeping, and reporting duties for cosmetic responsible persons. IFRA conformity and batch documentation from your manufacturer support safety substantiation but do not replace these obligations — confirm your role with a qualified U.S. compliance advisor.
The Modernization of Cosmetics Regulation Act (MoCRA), enacted in late 2022, expanded FDA authority over cosmetics—including perfume sold as cosmetic products. MoCRA is not a fragrance-specific law, but perfume brands are subject to its facility, listing, safety, and adverse event rules.
MoCRA does not replace IFRA industry standards or EU cosmetic rules if you export. Think of it as the U.S. baseline for responsible persons marketing cosmetic products domestically.
Responsible persons must register facilities that manufacture or process cosmetic products for U.S. distribution and list products with FDA. Many private label brands are the responsible person even when an overseas partner fills the product.
Confirm whether your manufacturer’s U.S. entity handles any registration on your behalf—most brands still need clarity on who lists the product under their brand name.
MoCRA requires serious adverse event reports to FDA within 15 business days, with follow-up records. Train customer service to escalate rash, hospitalization, or similar reports—not only “smells weak” complaints.
Maintain complaint logs tied to batch or lot codes printed on packaging.
Brands must maintain evidence that products are safe under labeled conditions of use. For fragrance, that typically includes IFRA conformity, supplier safety assessments, stability data, and batch COAs archived by lot.
MoCRA grants FDA access to safety and manufacturing records during inspections—disorganized files become compliance risk.
U.S. cosmetic labeling still requires product identity, net quantity, ingredient declaration, and responsible person name and address. MoCRA reinforced record-keeping around labeling accuracy.
Fragrance allergens are not labeled in the EU Annex III style in the U.S. at the time of writing, but ingredient transparency rules differ by market—do not assume one label works globally without review.
Before scaling U.S. sales: confirm responsible person role, register and list products per current FDA timelines, collect batch documentation from your manufacturer, and document safety rationale for your formula and format.
Work with a U.S. regulatory advisor for your specific entity structure—especially if you import finished goods or sell through large retailers with vendor compliance portals.
MoCRA registration and listing apply once you have a defined product identity — formula, concentration, packaging, and U.S. label artwork. Before you commit to bulk MOQ, validate how shortlisted scents perform on skin and in your bottle format.
Brandsamor curates five fragrances from a short brand brief so you can compare wear and positioning before production decisions — the same starting point whether you sell domestically or plan a U.S. import-ready launch. Typical batch documentation such as IFRA conformity and COA supports your safety files; your manufacturer can discuss what they provide for each project.
perfume manufacturer compliance documents
Before you approve bulk production, your perfume manufacturer should supply IFRA conformity, a batch Certificate of Analysis, allergen declarations where applicable, SDS for handling, and lot traceability tied to what ships on your label.
import private label perfume USA
Commercial import of private label perfume into the United States requires U.S.-compliant cosmetic labeling, customs entry with correct HTS classification, hazmat handling for alcohol-based fragrance, and batch documentation such as IFRA and COA. Work with a customs broker and confirm your manufacturer can fill to approved U.S. artwork.
IFRA certificate perfume
An IFRA certificate is a conformity statement from your fragrance supplier — not a product approval from IFRA itself. It shows a formula meets IFRA Standards for its intended category, such as fine fragrance spray.